MB
Therapeutic Areas
Bio Usawa Biotechnology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Rituximab Biosimilar | Non‑Hodgkin Lymphoma | Preclinical |
| Trastuzumab Biosimilar | HER2‑Positive Breast Cancer | Preclinical |
| Bevacizumab Biosimilar | Various Solid Tumors | Preclinical |
Leadership Team at Bio Usawa Biotechnology
RC
Richard Chin, MD
Co‑founder, Chair of Scientific Committee, Board Chairman
VA
Vince Anicetti
Board Member, Chairman of Manufacturing Advisory Board
PL
Patrick Lukulay, PhD
Chief Operating Officer & Chief Regulatory Officer